• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR ARMADA 35 PTA CATHETER; PERIPHERAL DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR ARMADA 35 PTA CATHETER; PERIPHERAL DILATATION CATHETER Back to Search Results
Catalog Number UNK ARMADA 35 OTW LL
Device Problems Deflation Problem (1149); Inflation Problem (1310); Patient-Device Incompatibility (2682)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/18/2022
Event Type  malfunction  
Manufacturer Narrative
B3: date of event ¿ estimated d4: the unique device identifier (udi) is unknown because the part number and lot number were not provided.The devices were not returned to abbott vascular for analysis.A review of the electronic lot history records (elhr), corrective action tracking system for the web (catsweb) database review and similar incident query for this product was not performed because the part/lot numbers were not reported.The investigation was unable to determine a conclusive cause for the reported inflation problem, deflation problem, and patient-device incompatibility.There is no indication of a product quality issue with respect to manufacture, design, or labeling.Attachment: rpt2135004 rev b titled; post market clinical follow-up evaluation report peripheral dilatation catheter family please see attachment for complete details.As multiple devices were captured in the pmcf report, the other devices referenced in the pmcf are filed under separate report numbersna.
 
Event Description
It was reported through a post market clinical follow up (pmcf) evaluation report identifying the armada 35 ll dilatation catheter that may be related to the following: adverse effects of dissection, perforation, embolism, occlusion/abrupt closure, pseudoaneurysm, and device issues of inflation and deflation issues, and inability to post-dilate a stent.Details are listed in the attached pmcf, titled post market clinical follow-up evaluation report peripheral dilatation catheter family please see the attached post market clinical follow up evaluation report for specific information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARMADA 35 PTA CATHETER
Type of Device
PERIPHERAL DILATATION CATHETER
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR COSTA RICA, REG # 3009564766
52 calle 3 b31 coyol free zone
el coyol alajuela
CS  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key16801782
MDR Text Key313943188
Report Number2024168-2023-04272
Device Sequence Number1
Product Code LIT
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
K111899
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Other
Type of Report Initial
Report Date 04/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/24/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK ARMADA 35 OTW LL
Was Device Available for Evaluation? No
Date Manufacturer Received03/29/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-